RxRights is closing its doors

February 27, 2017
For nearly seven years, RxRights has been fighting to promote and protect access to safe and affordable medicine. Regrettably, we’re going to be forced to close our doors at the end of the month. It pains us to announce this closure—especially as the drug pricing issue is gaining traction in the media and with legislators. We’ve ...
Read more -->


Top three insulin makers face class action lawsuit

February 2, 2017
We’ve been working with some allies concerned with the high cost of insulin. Through these connections, we found out about a class action lawsuit focused on insulin prices. The lawsuit, brought by a firm called Hagens Berman, alleges that the top three insulin manufacturers, Sanofi, Novo Nordisk and Eli Lilly, have been committing fraud by illegally raising ...
Read more -->


RxRights takes part in panel discussion on drug prices

February 1, 2017
Our lead organizer, Lee Graczyk, was part of a panel in Minneapolis last week organized by Senators Amy Klobuchar (D-MN) and Tammy Baldwin (D-WI) regarding drug prices. The panel discussed methods of lowering prescription drug prices related to the senators’ new legislation. In January, they introduced S.41, the Medicare Prescription Drug Price Negotiation Act—which would allow Medicare to ...
Read more -->


Amendment to allow drug importation fails

January 13, 2017
The process of dismantling the Affordable Care Act began in earnest earlier this week, as the Senate held a “vote-a-rama,” before passing the budget resolution ultimately designed to repeal the bill. During vote-a-rama, debate is limited but Senators are able to offer an unlimited number of amendments. Senators Bernie Sanders (I-VT) and Amy Klobuchar (D-MN) took ...
Read more -->


RxRights year in review – 2016

December 30, 2016
For more than six years, RxRights has been working to promote and protect your access to safe and affordable medicine. After Martin Skhreli raised a drug’s price 5000 percent overnight late in 2015, this year began with hope of serious action to reduce drug prices. While drug prices continued to overburden Americans in 2016, we’ve made ...
Read more -->


Who benefits from the 21st Century Cures Act?

December 8, 2016
After several years of negotiations, Congress has reached an agreement on the 21st Century Cures Act, a massive bill with a host of implications for healthcare spending. The bill sailed through the House on November 30 with a 392 to 26 vote. A majority of the Senate voted to end debate on the bill Monday night. ...
Read more -->


RxRights urges president elect to allow personal importation

December 2, 2016
President-elect Donald Trump is being urged to act immediately upon assuming office to explicitly legalize the personal importation of medicine from licensed registered pharmacies in (Tier One) countries whose standards of safety and efficacy meet or exceed those of the U.S. In an open letter to the President-elect from Lee Graczyk, lead organizer of RxRights, and ...
Read more -->


How do insulin prices impact Americans?

November 18, 2016
We recently surveyed our supporters regarding the high price of insulin and how it affects you and your friends/family members. Since it’s National Diabetes Awareness Month, it’s an appropriate time to report our findings. A total of 873 people responded; 653 said they don’t use insulin but care about the impact the high price of insulin ...
Read more -->


Legislators urge investigation into cost of insulin

November 4, 2016
You might recall that RxRights initiated a campaign last year regarding the skyrocketing price of insulin, based on your feedback. We enlisted your help to pressure drug makers and we’ve long been appealing to legislators. We’re pleased to see these efforts have been fruitful. The insulin issue is finally gaining traction with legislators and the ...
Read more -->


What are Rx Rights worth to you?

November 1, 2016
Do you find our updates about prescription drug pricing valuable? Do you save money because you import your medications from another country? If you answered “yes” to either of these questions, please think about how much you value our efforts to protect your access to affordable medicine. If you can, consider giving to the cause. We recognize ...
Read more -->


News Archives